New research from Sweden, published in the journal PLOS ONE, suggests that an old cancer drug may prevent immune rejection of transplanted donor tissue or organs. The discovery could lead to new treatments for autoimmune diseases - like rheumatoid arthritis or type 1 diabetes - where the person's own immune system attacks the body...
More...
More...